NOVOCURE LTD - NOTE 11/0

CUSIP: 67011XAB9

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Debt / NOTE 11/0
Market price (% of par)
86.86%
Total 13F principal
$396,659,196
Principal change
-$106,980,004
Total reported market value
$345,532,676
Number of holders
32
Value change
-$95,193,704
Number of buys
9
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 67011XAB9?
CUSIP 67011XAB9 identifies 67011XAB9 - NOVOCURE LTD - NOTE 11/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVOCURE LTD - NOTE 11/0 as of Q2 2022

As of 30 Jun 2022, NOVOCURE LTD - NOTE 11/0 was held by 32 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $396,659,196 in principal (par value) of the bond. The largest 10 bondholders included Allianz Asset Management GmbH, WOLVERINE ASSET MANAGEMENT LLC, STEELHEAD PARTNERS LLC, DeepCurrents Investment Group LLC, CAPSTONE INVESTMENT ADVISORS, LLC, Aequim Alternative Investments LP, CALAMOS ADVISORS LLC, D. E. Shaw & Co., Inc., Empyrean Capital Partners, LP, and SHENKMAN CAPITAL MANAGEMENT INC. This page lists 32 institutional bondholders reporting positions for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.